Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
JHL Forms $257 Million Partnership with Sanofi for Rituximab Biosimilar | December 5, 2016
Innovent Biologics Raises $260 Million in D Round, Setting a Record | November 29, 2016
Beijing's BeiGene Raises $200 Million in a Secondary Offering | November 22, 2016
Asymchem Labs, a Tianjin CMO, Raises $125 Million in Shenzhen IPO | November 18, 2016
Qiming Raises $222 Million in China RMB Venture Fund | November 9, 2016
Betta Pharma Completes $106 Million IPO in Shenzhen | November 7, 2016
Merck KGaA Opens $189 Million Nantong Pharma Plant; Plans $89 Million Life Science Center | November 4, 2016>> See all top stories...
ChinaBio® in the News